Zyban, Wellbutrin, Bupropion

Zyban, Wellbutrin, Bupropion Newswire

Comprehensive Real-Time News Feed for Zyban, Wellbutrin, Bupropion (generic).

Results 1 - 20 of 114 in Zyban, Wellbutrin, Bupropion (generic)

  1. Studies Suggest E-cigarettes May Aid QuittersRead the original story

    Wednesday Dec 17 | InteliHealth

    But it noted that there's not much research so far about these new devices. The report comes from the Cochrane Collaboration.


  2. MiloRead the original story w/Photo

    Wednesday Dec 17 | CFRB

    This is what happens when corporate funded, government approved bullying is allowed. For years, non-smoking advocates attacked smokers on the basis of the dangers posed by passive exposure to second hand smoke.


  3. 5 resolutions for a happy and healthy 2015Read the original story w/Photo

    Tuesday Dec 16 | Examiner.com

    As the days shorten, and the holidays approach, it's time to start thinking about making new resolutions for the coming year. While illnesses and medical conditions can not always be predicted, these five resolutions should be part of a plan for a health and happy new year.


  4. Immediately After A Stroke, Your Next Steps Are CrucialRead the original story w/Photo

    Friday Dec 12 | Switched

    Time is critical when someone has a stroke, but care can be delayed when victims, bystanders or even health workers don't recognize the emergency, a new study in the UK finds. Better public awareness of the signs of stroke and the importance of seeking immediate emergency care are needed, the authors say.


  5. This New Phone App Can Tell When You've Had Too Much To DrinkRead the original story w/Photo

    Friday Dec 12 | Switched

    A new federally funded cellphone app allows people who may have had one too many to get an idea just how drunk they are - and hail a ride home. Users enter their sex, height, weight, and number of drinks consumed to help figure out their blood-alcohol level.


  6. E-cigs help rid the world of smokersRead the original story w/Photo

    Sunday Dec 7 | Star Tribune

    By any other name they might be viewed as the smoking cessation tool they are rather than another dangerous tobacco product. During the last few years, electronic cigarettes have quietly become the most effective smoking cessation method available.


  7. Belviq And Smoking Cessation - Clearing The AirRead the original story w/Photo

    Monday Nov 24 | Seeking Alpha

    The concept of Belviq as a smoking cessation product has been something that I have been keen on for quite some time. While some investors and analysts have carried a focus on the concept of Belviq and phentermine, I have been beating the drum for the smoking cessation trials and data.


  8. Orexigen Announces Allowance of New U.S. Patent for ContraveA ...Read the original story

    Nov 21, 2014 | Sys-Con Media

    11/757,773, which covers use of Orexigen's sustained release formulation of naltrexone, which was designed to improve drug tolerability for ContraveA , in a method for treating obesity. The patent is expected to expire in March of 2028.


  9. Fired researcher was studying anti-smoking program, drugs that can cause severe reactionsRead the original story w/Photo

    Nov 20, 2014 | Vancouver Sun

    One of the two drugs offered by the Smoking Cessation Program - bupropion, marketed as Wellbutrin and Zyban - led to 64 hospitalizations last year in B.C. When PhD student Roderick MacIsaac was fired from the Ministry of Health, his study of an anti-smoking program that was to be used in the evaluation of B.C.'s controversial Smoking Cessation Program was halted. MacIsaac was one of seven ministry health researchers terminated in 2012, and he committed suicide in the months that followed.


  10. The Great American Smokeout is todayRead the original story

    Nov 20, 2014 | Char-Koosta News

    The Great American Smokeout is always the third Thursday of November each year and was established by the American Cancer Society as a day to encourage smokers to use the date as a beginning to a smoke-free life.


  11. Day Dedicated To Motivating Smokers To Kick The HabitRead the original story w/Photo

    Nov 20, 2014 | WOWT-TV Omaha

    Tobacco is the largest preventable cause of disease and premature death in the US, yet about 42 million Americans still smoke cigarettes. That's about one in every five adults.


  12. Harm from smoking cessation drug may be more common than thoughtRead the original story w/Photo

    Nov 19, 2014 | CBC News

    A drug used to help quit smoking and treat depression can lead to harm both accidentally and when abused, a poison control centre in British Columbia warns. B.C.'s Drug and Poison Information Centre said it handled 95 cases of buproprion exposure last year, including 22 that were admitted to critical care.


  13. Smoking cessation drug more harmful than previously thought: reportRead the original story w/Photo

    Nov 19, 2014 | Regina Leader Post

    Use of a popular smoking cessation and depression medication led to 64 hospitalizations - including 22 cases admitted to critical care - last year in B.C., according to the province's Drug and Poison Information Centre. The centre handled 95 calls last year about bupropion overdoses, including 22 cases where the wrong dosage was taken, 47 cases of suspected suicide attempts and nine cases of misuse or abuse.


  14. Ready to quit smoking? Here's what works bestRead the original story w/Photo

    Nov 16, 2014 | Windsor Beacon

    It's always a good time to quit smoking. But if smoking cessation has a season, it's about to begin.


  15. 'My partner won't stop smoking'Read the original story w/Photo

    Nov 12, 2014 | Iol.co.za

    QUESTION: My partner is a heavy smoker and, despite requests to him to smoke outside, I often come down to a smelly, fume-filled kitchen in the morning. Now that I'm retired I'm finding it hard to live with.


  16. Orexigen Rises as Weight Loss Drug Review ProceedsRead the original story w/Photo

    Nov 10, 2014 | Pharmaceutical Processing

    Shares of Orexigen Therapeutics Inc. jumped Monday after the company said a European Union review of its weight loss drug Contrave, which was approved in the U.S. in September, is progressing on schedule. Orexigen said it still having talks with an advisory committee about Contrave.


  17. Orexigen Therapeutics, Inc. Reports Results For The Third Quarter Ended September 30, 2014Read the original story

    Nov 10, 2014 | BioSpace

    "In addition to strong commercial resourcing, Takeda is bringing innovative approaches to the Contrave launch, by supporting the patient's complete approach to weight management with companion programs such as a weight loss program called Scale Down as well as Contrave Direct Save." Narachi continued: "Regarding the European Marketing Authorization Application for Mysimba for chronic weight management, we are pleased with the progress of the review.


  18. Orexigen Announces ContraveA (naltrexone HCI and bupropion HCI...Read the original story

    Oct 31, 2014 | Freshnews

    Orexigen Therapeutics today announced three Contrave and two disease awareness abstracts have been accepted for poster presentations at the upcoming ObesityWeek meeting. This meeting will be held November 2-7, 2014 in Boston at the Boston Convention and Exposition Center.


  19. Orexigen Therapeutics, Inc. Announces Contrave?? (naltrexone HCI And...Read the original story

    Oct 31, 2014 | BioSpace

    Orexigen Therapeutics, Inc. Announces ContraveA Data Presentations At The ObesityWeek Meeting In Boston /PRNewswire/ -- Orexigen Therapeutics today announced three ContraveA and two disease awareness abstracts have been accepted for poster presentations at the upcoming ObesityWeek meeting. This meeting will be held Food craving and weight loss: an integrated analysis of the effects of sustained-release naltrexone/bupropion on the cravings and mood sub-scales of the Control of Eating Questionnaire Weight Loss with sustained release naltrexone/bupropion as an adjunct to intensive behavior modification: A subgroup analysis in African American and white subjects.


  20. FDA: little evidence to drop Chantix boxed warningRead the original story

    Oct 24, 2014 | Foster's Daily Democrat

    Federal regulators say Pfizer has provided low-quality evidence to support its request to remove a bold-letter warning from its anti-smoking drug Chantix about suicidal behavior. The twice-a-day tablet has carried the Food and Drug Administration's strongest warning label, known as a black box, since 2009 following reports of suicidality, hostility and depression among some patients.